Michael Robert Martin, Chief Business Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 44,000 shares at $21.80 ($958K) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Open-market sale of $958k AUPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.73 | 14,000 | $304K | 31.7% |
| 2 | $21.80 | 30,000 | $654K | 68.3% |
| Total | $21.78 avg | 44,000 | $958K | 100% |
| Filing → |
| AUPH | SELL | 2021-11-12 | $4.5M | — | Filing → |
| AUPH | SELL | 2021-11-03 | $1.4M | — | Filing → |
| AUPH | SELL | 2021-09-22 | $2.7M | — | Filing → |